Amram Kupietzky

Dr. Amram Kupietzky

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Journal of Surgical Research
Verified
Journal Article
Closed access
AAAbbas Al-Kurd
Abbas Al-Kurd
IMIdo Mizrahi
Ido Mizrahi
BSBaha Siam
Baha Siam
AKAmram Kupietzky
Amram Kupietzky
NHNurith Hiller
Nurith Hiller
HMHaggi Mazeh
Haggi Mazeh

19 July 2018 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
AAAbbas Al-Kurd
Abbas Al-Kurd
RGRonit Grinbaum
Ronit Grinbaum
AAAla’a Abubeih
Ala’a Abubeih
AVAriel Verbner
Ariel Verbner
AKAmram Kupietzky
Amram Kupietzky
NBNahum Beglaibter
Nahum Beglaibter

19 December 2022 in Cancers
Verified
Journal Article
Open access
PDF file
AKAmram Kupietzky
Amram Kupietzky
AAArie Ariche
Arie Ariche
Intrahepatic cholangiocarcinoma (ICC) is a rare and aggressive malignancy. It originates from the bile ducts and is the second most common primary cancer of the liver. Surgery is considered the only curative treatment of ICC, offering the best chance for long-term survival. The purpose of this article is to review the available literature on ICC, with a focus on the various aspects of the surgical care in this potentially lethal malignancy.

5 September 2022 in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
Verified
Journal Article
Closed access
SSSheer Shabat
Sheer Shabat
DFDanielle Furman
Danielle Furman
AKAmram Kupietzky
Amram Kupietzky
BSBotros B.Med.Sc Srour
Botros B.Med.Sc Srour
TMTzlil Mordechai-Heyn
Tzlil Mordechai-Heyn
IMIdo Mizrahi
Ido Mizrahi
Background: Endoscopic thoracoscopic sympathectomy (ETS) is the gold standard therapy for primary focal palmar hyperhidrosis (PFPH), resulting in high patient satisfaction rates. The most common side effect of ETS is compensatory hyperhidrosis (CH). Previous studies followed patients’ satisfaction degree of surgery and the incidence of CH during a limited follow-up period of 1 to 3 years. The purpose of this study was to investigate the long-term outcomes and patient satisfaction after ETS. Materials and Methods: After approval of our institutional review board, we conducted a retrospective review of all consecutive patients who underwent ETS for PFPH at our institution between 1998 and 2019. Electronic medical records were reviewed for short-term outcomes. Long-term outcomes were collected through telephone questionnaires. Primary outcome was the resolution of PFPH. Secondary outcomes were CH and long-term patient satisfaction. Results: During the study period, 256 patients underwent ETS to treat primary focal palmar hyperhidrosis at our institution between the years 1998-2019. One-hundred and fifty (58.6%) patients agreed to participate in the study and were included in the final analysis. The mean age was 23.8 (17 to 58) years, 56% were females. The mean follow-up time was 11±6.1 (1 to 22) years. Ninety-four percent reported resolution of PFPH; however, CH was reported by 90% of participants. CH decreased mean patient satisfaction score from 4.8±0.5 to 3.8±2 (P=0.009). This effect was more pronounced in patients with CH of the head and neck (P=0.009). Patients’ satisfaction decreased over time from a mean of 4.8±0.4 in the first year after surgery to a mean of 3.7±1.4 12 years or more after surgery (P <0.001). Despite this, 79% of patients reported they would recommend ETS to other patients. Conclusions: ETS for PFPH is highly effective and results in high patient satisfaction rates even after long-term follow-up. Despite high rates of postoperative CH, nearly 80% of patients would still recommend the procedure to fellow patients, justifying its reputation as the gold standard treatment for PFPH.

27 September 2021 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
SSShahaf Shay
Shahaf Shay
AKAmram Kupietzky
Amram Kupietzky
DWDaniel Joshua Weiss
Daniel Joshua Weiss
RDRoi Dover
Roi Dover
NLNachum Emil Eliezer Lourie
Nachum Emil Eliezer Lourie
IMIdo Mizrahi
Ido Mizrahi

24 May 2024 in Obesity Surgery
Verified
Journal Article
Closed access
AKAmram Kupietzky
Amram Kupietzky
ODOmri Dodi
Omri Dodi
NCNoa Cohen
Noa Cohen
RDRoi Dover
Roi Dover
AMAta Maden
Ata Maden
IMIdo Mizrahi
Ido Mizrahi